Purchase Order 75N92024P00191
- Not listed
- This $13,265.25 firm-fixed-price purchase order was awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services, to Biolegend, Inc., a for-profit manufacturer of biomedical reagents and antibodies. The contract is for the supply of antibodies and kits to support cell isolation research that may affect the immune system. Biolegend is a specialized supplier of products used in immunology, oncology, neuroscience, and cell biology...
- This is a $14,856.75 firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Biolegend, Inc., a for-profit manufacturer and supplier of biomedical reagents, antibodies, proteins, and other products supporting life science research and drug discovery. The award is for the provision of reagents and kits, with an ultimate completion date of May 28, 2025. Biolegend has previously served as a subcontractor to Parsons Government Services Inc. on...
- This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Biolegend, Inc., a for-profit manufacturer and supplier of biomedical reagents, antibodies, proteins, and other products for life science research and drug discovery. The $3,500.51 contract is to provide a variety of specialized reagents and products, such as oligonucleotide-tagged antibodies, TotalSeq antibody panels, and custom human antibody panels, to support research initiatives...
- This federal contract award is for BIOLEGEND TOTALSEQ-C REAGENTS with a ceiling value of $48,965.00. The contract was awarded by the National Heart Lung and Blood Institute, a civilian agency within the National Institutes of Health (NIH), to Biolegend, Inc., a for-profit manufacturer of biomedical reagents, antibodies, and scientific research products located in San Diego, California. The contract is a firm fixed-price purchase order with an ultimate completion date of October 9, 2025. The...
- This $9,343.50 firm-fixed-price purchase order was awarded to Biolegend, Inc., a for-profit manufacturer and supplier of biomedical reagents, antibodies, proteins, and other products supporting life science research and drug discovery. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS). The award supports Biolegend's provision of specialized products, including oligonucleotide-tagged...
- This is a firm fixed-price purchase order contract awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, to Biolegend, Inc., a for-profit manufacturer of biomedical reagents, antibodies, proteins, and other scientific research products located in San Diego, California. The contract is for the procurement of biological and reagent materials, specifically Biolegend flow cytometer antibodies, with a ceiling value of $14,042.25...
- The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order contract to BioLegend, Inc., a for-profit manufacturer of biomedical reagents, antibodies, proteins, and other products to support life science research and drug discovery. The $26,552.50 contract is for the procurement of a TOTALSEQ-A antibody conjugate panel and two additional anti-human antibodies for...
- This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Biolegend, Inc. for the supply of various biomedical research reagents and antibodies. The $3,088.75 contract supports research efforts across multiple federal agencies, particularly within the NIAID. Biolegend, a for-profit manufacturer of life science research products, has a history of providing specialized...
- This firm-fixed-price purchase order contract, valued at $14,906.75, was awarded by the National Cancer Institute to Biolegend, Inc., a for-profit manufacturer and supplier of biomedical reagents, antibodies, proteins, and other products. The contract is for the delivery of 30 different antibodies to support multi-parameter flow cytometric analyses of circulating immune subsets in over 230 clinical samples as part of a clinical trial protocol. The contract does not have a set-aside...
- Biolegend, Inc. has been awarded a firm fixed price purchase order contract valued at twenty-four thousand five hundred sixty-one dollars and seventy-five cents ($24,561.75) by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases. The contract is for the delivery of BIOLEGEND ANTIBODIES with performance through September 30, 2023. As a manufacturer of biomedical reagents, antibodies, proteins, and other products to...
This is a firm-fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Biolegend, Inc., a for-profit manufacturer of biomedical reagents, antibodies, and research products. The $23,028.75 contract is for the provision of CITEsequencing kits to support staining and labeling research being conducted by the NHLBI DIR Wiley Lab. The award has no set-aside designation and is not associated with a larger contract vehicle. Biolegend is a specialized supplier of a wide range of reagents, antibodies, and kits that support various biomedical research efforts across multiple NIH institutes and the Department of Veterans Affairs. The company's products have been utilized in research across diverse areas such as COVID-19, multiple sclerosis, infectious diseases, immunology, and oncology.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.0k | 6/17/24 |